BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26911351)

  • 41. Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations.
    Bülow L; Lissewski C; Bressel R; Rauch A; Stark Z; Zenker M; Bartsch O
    Am J Med Genet A; 2015 Feb; 167A(2):394-9. PubMed ID: 25358541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
    Niemeyer CM; Flotho C
    Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical features and prognosis of juvenile myelomonocytic leukemia: an analysis of 63 cases].
    Yang WY; Liu LP; Liu F; Qi BQ; Chang LX; Zhang L; Chen XJ; Zou Y; Chen YM; Guo Y; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):265-271. PubMed ID: 36946161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphologic and Immunophenotypic Differences in Juvenile Myelomonocytic Leukemias With CBL and Other Canonical RAS-pathway Gene Mutations: A Single Institutional Experience.
    Mariani RA; Jennings L; Zhang S; Bhat R; Gong S
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e819-e825. PubMed ID: 33769390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia.
    Pearson S; Guo B; Pierce A; Azadbakht N; Brazzatti JA; Patassini S; Mulero-Navarro S; Meyer S; Flotho C; Gelb BD; Whetton AD
    J Proteome Res; 2020 Jan; 19(1):194-203. PubMed ID: 31657576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.
    Loh ML
    Hematology Am Soc Hematol Educ Program; 2010; 2010():357-62. PubMed ID: 21239819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
    Stieglitz E; Ward AF; Gerbing RB; Alonzo TA; Arceci RJ; Liu YL; Emanuel PD; Widemann BC; Cheng JW; Jayaprakash N; Balis FM; Castleberry RP; Bunin NJ; Loh ML; Cooper TM
    Pediatr Blood Cancer; 2015 Apr; 62(4):629-36. PubMed ID: 25704135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.
    Mason-Suares H; Toledo D; Gekas J; Lafferty KA; Meeks N; Pacheco MC; Sharpe D; Mullen TE; Lebo MS
    Eur J Hum Genet; 2017 Apr; 25(4):509-511. PubMed ID: 28098151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
    Koike K; Matsuda K
    Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL.
    Gagne AL; Maguire JA; Gandre-Babbe S; Chou ST; Tasian SK; Loh ML; Weiss MJ; Gadue P; French DL
    Stem Cell Res; 2018 Aug; 31():157-160. PubMed ID: 30096712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS.
    Ly B; Modi A; Rogers HJ; Makishima H; Hanna R; Cook JR; Theil KS; Maciejewski JP
    Pediatr Blood Cancer; 2014 May; 61(5):946-8. PubMed ID: 24610751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
    Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
    Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloproliferative disorder in Noonan syndrome.
    Bastida P; García-Miñaúr S; Ezquieta B; Dapena JL; Sanchez de Toledo J
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e43-5. PubMed ID: 20829714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia.
    Doisaki S; Muramatsu H; Shimada A; Takahashi Y; Mori-Ezaki M; Sato M; Kawaguchi H; Kinoshita A; Sotomatsu M; Hayashi Y; Furukawa-Hibi Y; Yamada K; Hoshino H; Kiyoi H; Yoshida N; Sakaguchi H; Narita A; Wang X; Ismael O; Xu Y; Nishio N; Tanaka M; Hama A; Koike K; Kojima S
    Blood; 2012 Aug; 120(7):1485-8. PubMed ID: 22753870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acquired uniparental disomy and c-CBL mutation in myelodysplastic syndromes.
    Sanada M
    Rinsho Ketsueki; 2011 Jun; 52(6):342-9. PubMed ID: 21737985
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia.
    Maschan AA; Khachatrian LA; Solopova GG; Ossipova EY; Baidun LV; Dmitrieva SV; Maschan MA; Resnik IB
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e32-4. PubMed ID: 21102353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
    De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adult-onset acute myeloid leukaemia in a patient with germline mutation of CBL.
    Ali AM; Cooper J; Walker A; Jones D; Saad A
    Br J Haematol; 2021 Feb; 192(3):665-667. PubMed ID: 33216958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.